scholarly journals Optimizing dendritic cell vaccine for immunotherapy in multiple myeloma: tumour lysates are more potent tumour antigens than idiotype protein to promote anti-tumour immunity

2012 ◽  
Vol 170 (2) ◽  
pp. 167-177 ◽  
Author(s):  
S. Hong ◽  
H. Li ◽  
J. Qian ◽  
J. Yang ◽  
Y. Lu ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Dendritic Cell ◽  
Dendritic Cell Vaccine ◽  
Cell Vaccine ◽  
Tumour Immunity ◽  
Tumour Antigens

scholarly journals Efficacy and safety of Id-protein-loaded dendritic cell vaccine in patients with multiple myeloma – Phase II study results

Neoplasma ◽  
2012 ◽  
Vol 59 (04) ◽  
pp. 440-449 ◽  
Author(s):  
L. ZAHRADOVA ◽  
K. MOLLOVA ◽  
D. OCADLIKOVA ◽  
L. KOVAROVA ◽  
Z. ADAM ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Dendritic Cell ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Dendritic Cell Vaccine ◽  
Cell Vaccine ◽  
Efficacy And Safety ◽  
Study Results ◽  
Id Protein

Results of a Phase II clinical trial with Id-protein-loaded dendritic cell vaccine in multiple myeloma: encouraging or discouraging?

Immunotherapy ◽  
2012 ◽  
Vol 4 (10) ◽  
pp. 991-994 ◽  
Author(s):  
Maria A Garcia-Marquez ◽  
Kerstin Wennhold ◽  
Andreas Draube ◽  
Michael von Bergwelt-Baildon
Keyword(s):  
Clinical Trial ◽  
Multiple Myeloma ◽  
Dendritic Cell ◽  
Phase Ii ◽  
Dendritic Cell Vaccine ◽  
Phase Ii Clinical Trial ◽  
Cell Vaccine ◽  
Id Protein

Construction of PSA-specific dendritic cell vaccine and its in vitro immune activity

2009 ◽  
Vol 29 (3) ◽  
pp. 265-270
Author(s):  
Dan-feng XU ◽  
Yi GAO ◽  
Yu-shan LIU ◽  
Xin-gang CUI ◽  
Jian-ping CHE ◽  
...  
Keyword(s):  
Dendritic Cell ◽  
Dendritic Cell Vaccine ◽  
Cell Vaccine ◽  
Immune Activity

scholarly journals 423. The Combination of p53 Dendritic Cell Vaccine and Ad-p53 Gene Therapy Against p53 Overexpressing and p53 Deleted Tumor Cell Lines

2015 ◽  
Vol 23 ◽  
pp. S167
Author(s):  
Hiroki Saito ◽  
Koichi Kitagawa ◽  
Risa Yamasaki ◽  
Nami Katai ◽  
Naoya Morishita ◽  
...  
Keyword(s):  
Gene Therapy ◽  
Dendritic Cell ◽  
Tumor Cell ◽  
Cell Lines ◽  
P53 Gene ◽  
Dendritic Cell Vaccine ◽  
Cell Vaccine ◽  
Tumor Cell Lines

Single Injection of CD34+ Progenitor-Derived Dendritic Cell Vaccine Can Lead to Induction of T-Cell Immunity in Patients With Stage IV Melanoma

2003 ◽  
Vol 26 (5) ◽  
pp. 432-439 ◽  
Author(s):  
A. Karolina Palucka ◽  
Madhav V. Dhodapkar ◽  
Sophie Paczesny ◽  
Susan Burkeholder ◽  
Knut M. Wittkowski ◽  
...  
Keyword(s):  
T Cell ◽  
Dendritic Cell ◽  
Single Injection ◽  
Stage Iv ◽  
Dendritic Cell Vaccine ◽  
T Cell Immunity ◽  
Cell Vaccine ◽  
Cell Immunity ◽  
Stage Iv Melanoma
Sign in / Sign up

Export Citation Format

Share Document